April 2017
Volume 58, Issue 4
Open Access
Research Highlight  |   April 2017
Bright Light Blocks the Development of Form Deprivation Myopia in Mice, Acting on D1 Dopamine Receptors
Author Affiliations
  • Ian G. Morgan
    Research School of Biology, Australian National University, Canberra, Australia; ian.morgan@anu.edu.au
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yatsen University, Guangzhou, China
  • Regan S. Ashby
    Centre for Research in Therapeutic Solutions, Health Research Institute, Faculty of Education, Science, Technology and Mathematics, University of Canberra, Canberra, Australia
Investigative Ophthalmology & Visual Science April 2017, Vol.58, 2317. doi:https://doi.org/10.1167/iovs.17-21871
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ian G. Morgan, Regan S. Ashby; Bright Light Blocks the Development of Form Deprivation Myopia in Mice, Acting on D1 Dopamine Receptors. Invest. Ophthalmol. Vis. Sci. 2017;58(4):2317. doi: https://doi.org/10.1167/iovs.17-21871.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements
Chen et al.1 provide more evidence, using the mouse myopia model, to support the idea that bright light suppresses the development of myopia via increased dopamine release. They show that the cells activated by bright light, delineated by increased expression of phosphorylated tyrosine hydroxylase and c-fos, are predominantly ON-bipolar cells, which are known to stimulate the release of dopamine from dopaminergic amacrine cells.2 The protective effects of bright light against form-deprivation myopia seen in nonhuman primates3 make it likely that similar dopamine-mediated effects will be seen in children, where it is known that more time outdoors, where light is much brighter than indoors during the day, slows the onset of myopia. However, the results of Chen et al.1 are unusual in that the protective effect of light appears to be mediated by D1 dopamine receptors, with the protective effect blocked by the relatively selective D1 receptor antagonist SCH39166. Most other studies have suggested that D2 dopamine receptors are involved, although the pharmacologic characterization of receptors is very limited. The possibility of interactions between the D1 and D2 pathways has also been raised (see Feldkaemper and Schaeffel4 for a review). Given the increasing use of increased time outdoors to control the development of myopia in children, the receptors involved now require more detailed pharmacologic characterization, particularly if the use of dopamine agonists for myopia control is to be considered. One further issue that needs resolution is whether the involvement of D1 dopamine receptors is a feature of mammalian retinas, or of retinas adapted for living in low light rather than bright light conditions or a more general feature of control of eye growth. 
Chen S, Zhi Z, Ruan Q, et al. Bright light suppresses form-deprivation myopia development with activation of dopamine D1 receptor signaling in the ON pathway in retina. Invest Ophthalmol Vis Sci. 2017; 58: 2306–2316.
Boelen MK, Boelen MG, Marshak DW. Light-stimulated release of dopamine from the primate retina is blocked by 1-2-amino-4-phosphonobutyric acid (APB). Vis Neurosci. 1998; 15: 97–103.
Smith ELIII, Hung LF, Huang J. Protective effects of high ambient lighting on the development of form-deprivation myopia in rhesus monkeys. Invest Ophthalmol Vis Sci. 2012; 53: 421–428.
Feldkaemper M, Schaeffel F. An updated view on the role of dopamine in myopia. Exp Eye Res. 2013; 114: 106–119.

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.